IAG Releases DYNAMIKA V.7, the Cloud Platform for Imaging in Clinical Trials
2 December, London, UK — New Release of DYNAMIKA V.7, IAG’s Cloud Platform for Imaging in Clinical Trials Achieves BSI Surveillance Audit Certification
Today, Image Analysis Group (IAG) proudly announces that the team has successfully passed the British Standards Institute (BSI) surveillance audit with its latest release of the cloud based platform for management and central review of imaging in clinical trials, DYNAMIKA V.7.
DYNAMIKA has been developed in compliance with both 21CFR Part 11 and ISO 13485 underscoring the company’s commitment to maintaining the highest standards of quality and compliance in its operations, while pushing boundaries of innovation in clinical research.
‘Having such comprehensive quality compliance enables IAG to partner with companies seeking effective imaging biomarkers to support safety and efficacy of their drug candidates in clinical trials, as well as those who envision utilizing these imaging endpoints in clinical settings, as companion diagnostic,’ said Dr Olga Kubassova, President of IAG.
DYNAMIKA brings smart workflows for data management, quality control and central review, and offers simple integration with AI tools. It helps to accelerate the radiological reading process and reduce burden on the sites uploading the images.
DYNAMIKA V7 improves ability for the trial operational leaders to have real-time visibility into trial management and stakeholder performance.
‘What sets DYNAMIKA apart is its role as a cloud-native enterprise platform that serves as a bridge between the translational, clinical and medical affairs teams, allowing managing imaging in phase 1, phase 2 and 3 trials efficiently and to the maximum benefit of all stakeholders,’ said Jon Himoff, IAG’s Chief Product Officer.
‘The successful BSI audit and re-certification follow IAG’s recent attainment of SOC 2 Type 1 compliance, showcasing the company’s dedication to data security,’ said Max Felman, Head of Quality Assurance
As evidenced by the audit processes, IAG’s teams are committed to ensuring that clients can trust the company to safeguard their data while delivering exceptional value.
‘This milestone another important step as Image Analysis Group continues bring innovation and optimised data flows to the medical imaging space’, added Roughan Sheedy, IAG’s CEO
For more information about Image Analysis Group and its services, visit www.ia-grp.com
About DYNAMIKA, Cloud Based Imaging Trial Data Management Platform
DYNAMIKA is a state-of-the-art cloud-based platform developed by Image Analysis Group that simplifies and automates the management and analysis of imaging data in clinical trials.
Designed for flexibility and efficiency, DYNAMIKA integrates role-based workflows to reduce site burden and increase their participation. It brings together state-of-the art image review methods and advanced imaging with robust workflows, facilitating greater consistency in radiological reads and helping Investigators to improve ability to assess drug efficacy and safety through novel insights.
The platform supports various aspects of phase I-IV clinical trials, from delivering flexible infrastructure to support trial design and patient stratification to real-time data quality monitoring and reporting.
One of the key advantages of DYNAMIKA is its ability to facilitate data interoperability, ensuring that information from multiple sources is consolidated and easily accessible. This capability allows clinical trial teams to make informed decisions based on comprehensive insights derived from imaging data.
Additionally, DYNAMIKA’s user-friendly interface and image Viewer promotes collaboration among stakeholders, fostering efficient communication and coordination throughout the trial process. As clinical research evolves, DYNAMIKA positions itself as an essential tool for organizations seeking to optimize their imaging processes and accelerate the development of innovative therapies.
By harnessing the power of artificial intelligence, DYNAMIKA not only streamlines workflows but also enhances the accuracy and reliability of imaging assessments, ultimately contributing to improved trial outcomes.
About Image Analysis Group (IAG)
Leading imaging Clinical Research Organization (iCRO) that combines medical and operational expertise with cutting-edge proprietary technologies to more efficiently advance drug development, and to deliver the potential for companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to IV imaging trials across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.
Reach out: imaging.experts@ia-grp.com
Follow the Company: Linkedin